Edit Content

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Clinical Trial Imaging Market to reach USD 1.71 billion by the end of 2030

Global Clinical Trial Imaging Market Size study & Forecast, by Product and Service (Trial Design Consulting Services, Read Analysis Services, Operational Imaging Services, Imaging Software), by Modality (Magnetic Resonance Imaging, Computed Tomography, Ultrasound, Positron Emission Tomography, X-Ray, Other Modalities), by End-User and Regional Analysis, 2023-2030

Product Code: HLSMD-88634733
Publish Date: 20-02-2024
Page: 200

Global Clinical Trial Imaging Market is valued at approximately USD 1.13 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 5.38% during the forecast period 2023-2030. Clinical Trial Imaging refers to the use of various imaging techniques and technologies to assess and monitor the effects of a medical intervention, such as a new drug or medical device, during a clinical trial. These trials are conducted to evaluate the safety and efficacy of the intervention in human subjects. The Clinical Trial Imaging Market is expanding because of factors such as the increasing number of clinical trials and the growing number of Contract Research Organizations (CROs). Imaging plays a crucial role in clinical trials by providing detailed visual information about the anatomy, physiology, and function of the human body. As a result, the demand for Clinical Trial Imaging has progressively increased in the international market during the forecast period 2023-2030.

Regulatory bodies play a crucial role in approving new medical interventions, and imaging data often contribute to these decisions. The increasing number of trials could lead to more extensive regulatory scrutiny, emphasizing the importance of adhering to guidelines for imaging data acquisition, analysis, and reporting. According to Statista, the number of registered clinical studies in non-U.S. areas was approximately 242 thousand, whereas the number in the United States was more than 141 thousand. Another important factor that drives the Clinical Trial Imaging Market is the increasing number of Contract Research Organizations (CROs) that can facilitate the efficient start-up of clinical trials by streamlining the process of selecting imaging sites, implementing standardized imaging protocols, and ensuring compliance with regulatory requirements. This efficiency can positively impact the overall timeline of the clinical trial. In addition, as per Statista, in 2023, the anticipated global market size for Contract Research Organizations (CROs) accounts for approximately USD 77 billion worldwide and is projected to reach up to USD 127.3 billion by the year 2028. Moreover, the surge in R&D expenditure in pharmaceutical and biotechnological companies and rising healthcare expenditure across the world are anticipated to create lucrative growth opportunities for the market over the forecast period. However, high-risk Radiation Causing Diseases and stringent regulatory policies are going to impede overall market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Clinical Trial Imaging Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the presence of major outsourcing companies such as Charles River Laboratories International, Inc., IQVIA Inc., and so on along with the increasing number of research and development activities in the region. R&D initiatives lead to a better understanding of disease mechanisms and treatment effects. This knowledge allows for the development of customized imaging protocols tailored to specific therapeutic areas, optimizing the relevance and efficiency of clinical trial imaging. The region’s dominant performance is anticipated to propel the overall demand for Clinical Trial Imaging. Furthermore, Asia Pacific is expected to grow fastest over the forecast period, owing to factors such as rapid growth of the population, and increased research and development activities in the region.

Major market player included in this report are:
Navitas Life Sciences
Resonance Health Ltd
ProScan Imaging
Radiant Sage LLC
Medpace Holdings, Inc.
Biomedical Systems Corp
Cardiovascular Imaging Technologies
Intrinsic Imaging LLC
BioTelemetry Inc

Recent Developments in the Market:
Ø In September 2023, Mayo Clinic and GE HealthCare unveiled a strategic alliance in healthcare, focusing on collaborative research and product development initiatives. This partnership is designed to revolutionize the interactions between patients and healthcare professionals within radiology practices and the administration of innovative therapies. Named the Strategic Collaboration for Innovation in Medical Imaging and Theranostics, this initiative brings together a team of experts from Mayo Clinic and GE HealthCare, including scientists, technology developers, clinicians, and other healthcare providers. The primary objective of this collaboration is to empower clinicians with advanced technology for precise diagnosis and treatment of medical conditions. Additionally, the partnership aims to enhance the patient experience by integrating novel technologies and approaches to medical imaging and theranostics, thereby personalizing each phase of the patient’s care journey.

Global Clinical Trial Imaging Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Product and Service, Modality, End-User, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product and Service
Trial Design Consulting Services
Read Analysis Services
Operational Imaging Services
Imaging Software

By Modality
Magnetic Resonance Imaging
Computed Tomography
Positron Emission Tomography
Other Modalities

By End-User
Pharmaceutical & Biotechnology Companies
Medical Device Manufacturers
Academic and Government Research Institutes

By Region:

North America


Asia Pacific
South Korea

Latin America

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Clinical Trial Imaging Market, by Region, 2020-2030 (USD Billion)
1.2.2. Clinical Trial Imaging Market, by Product and Service, 2020-2030 (USD Billion)
1.2.3. Clinical Trial Imaging Market, by Modality, 2020-2030 (USD Billion)
1.2.4. Clinical Trial Imaging Market, by End-User, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Clinical Trial Imaging Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Clinical Trial Imaging Market Dynamics
3.1. Clinical Trial Imaging Market Impact Analysis (2020-2030)
3.1.1. Market Drivers Increasing number of clinical trials Growing number of Contract Research Organizations (CROs)
3.1.2. Market Challenges High-Risk Radiation Causing Diseases Stringent Regulatory Policies

3.1.3. Market Opportunities Surge in R&D expenditure in pharmaceutical and biotechnological companies Rise in Healthcare Expenditure across the world

Chapter 4. Global Clinical Trial Imaging Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Clinical Trial Imaging Market, by Product and Service
5.1. Market Snapshot
5.2. Global Clinical Trial Imaging Market by Product and Service, Performance – Potential Analysis
5.3. Global Clinical Trial Imaging Market Estimates & Forecasts by Product and Service 2020-2030 (USD Billion)
5.4. Clinical Trial Imaging Market, Sub Segment Analysis
5.4.1. Trial Design Consulting Services
5.4.2. Read Analysis Services
5.4.3. Operational Imaging Services
5.4.4. Imaging Software
Chapter 6. Global Clinical Trial Imaging Market, by Modality
6.1. Market Snapshot
6.2. Global Clinical Trial Imaging Market by Modality, Performance – Potential Analysis
6.3. Global Clinical Trial Imaging Market Estimates & Forecasts by Modality 2020-2030 (USD Billion)
6.4. Clinical Trial Imaging Market, Sub Segment Analysis
6.4.1. Magnetic Resonance Imaging
6.4.2. Computed Tomography
6.4.3. Ultrasound
6.4.4. Positron Emission Tomography
6.4.5. X-Ray
6.4.6. Echocardiography
6.4.7. Other Modalities
Chapter 7. Global Clinical Trial Imaging Market, by End-User
7.1. Market Snapshot
7.2. Global Clinical Trial Imaging Market by End-User, Performance – Potential Analysis
7.3. Global Clinical Trial Imaging Market Estimates & Forecasts by End-User 2020-2030 (USD Billion)
7.4. Clinical Trial Imaging Market, Sub Segment Analysis
7.4.1. Pharmaceutical & Biotechnology Companies
7.4.2. Medical Device Manufacturers
7.4.3. Academic and Government Research Institutes
Chapter 8. Global Clinical Trial Imaging Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Clinical Trial Imaging Market, Regional Market Snapshot
8.4. North America Clinical Trial Imaging Market
8.4.1. U.S. Clinical Trial Imaging Market Product and Service breakdown estimates & forecasts, 2020-2030 Modality breakdown estimates & forecasts, 2020-2030 End-User breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Clinical Trial Imaging Market
8.5. Europe Clinical Trial Imaging Market Snapshot
8.5.1. U.K. Clinical Trial Imaging Market
8.5.2. Germany Clinical Trial Imaging Market
8.5.3. France Clinical Trial Imaging Market
8.5.4. Spain Clinical Trial Imaging Market
8.5.5. Italy Clinical Trial Imaging Market
8.5.6. Rest of Europe Clinical Trial Imaging Market
8.6. Asia-Pacific Clinical Trial Imaging Market Snapshot
8.6.1. China Clinical Trial Imaging Market
8.6.2. India Clinical Trial Imaging Market
8.6.3. Japan Clinical Trial Imaging Market
8.6.4. Australia Clinical Trial Imaging Market
8.6.5. South Korea Clinical Trial Imaging Market
8.6.6. Rest of Asia Pacific Clinical Trial Imaging Market
8.7. Latin America Clinical Trial Imaging Market Snapshot
8.7.1. Brazil Clinical Trial Imaging Market
8.7.2. Mexico Clinical Trial Imaging Market
8.8. Middle East & Africa Clinical Trial Imaging Market
8.8.1. Saudi Arabia Clinical Trial Imaging Market
8.8.2. South Africa Clinical Trial Imaging Market
8.8.3. Rest of Middle East & Africa Clinical Trial Imaging Market

Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. IXICO plc Key Information Overview Financial (Subject to Data Availability) Product Summary Recent Developments
9.3.2. Navitas Life Sciences
9.3.3. Resonance Health Ltd
9.3.4. ProScan Imaging
9.3.5. Radiant Sage LLC
9.3.6. Medpace Holdings, Inc
9.3.7. Biomedical Systems Corp
9.3.8. Cardiovascular Imaging Technologies
9.3.9. Intrinsic Imaging LLC
9.3.10. BioTelemetry, Inc
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com


Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now